Liquid biopsy: circulating tumor DNA monitors neoadjuvant chemotherapy response and prognosis in stage II/III gastric cancer

A good response to neoadjuvant chemotherapy (NACT) is strongly associated with a higher curative resection rate and favorable outcomes for patients with gastric cancer (GC). We examined the utility of serial circulating tumor DNA (ctDNA) testing for monitoring NACT response and prognosis in stage II...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Meng, Yang, Heli, Fu, Tao, Meng, Meizhu, Feng, Yi, Qu, Changda, Li, Zhongwu, Xing, Xiaofang, Li, Wenmei, Ye, Meiying, Li, Sisi, Bu, Zhaode, Jia, Shuqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483607/
https://www.ncbi.nlm.nih.gov/pubmed/37356061
http://dx.doi.org/10.1002/1878-0261.13481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483607/
https://www.ncbi.nlm.nih.gov/pubmed/37356061
http://dx.doi.org/10.1002/1878-0261.13481

Ejemplares similares